Polyamine content of Pneumocystis carinii and response to the ornithine decarboxylase inhibitor DL-α-difluoromethylornithineSALIM MERALI; CLARKSON, A. B.Antimicrobial agents and chemotherapy. 1996, Vol 40, Num 4, pp 973-978, issn 0066-4804Article

Polyamine analysis using N-hydroxysuccinimidyl-6-aminoquinoyl carbamate for pre-column derivatizationMERALI, S; CLARKSON, A. B.Journal of chromatography. B, Biomedical applications. 1996, Vol 675, Num 2, pp 321-326Article

Trophozoite elimination in a rat model of Pneumocystic carinii pneumonia by clinically achievable plasma deferoxamine concentrationsMERALI, S; CHIN, K; GRADY, R. W et al.Antimicrobial agents and chemotherapy. 1996, Vol 40, Num 5, pp 1298-1300, issn 0066-4804Article

Mitochondrial development in Trypanosoma brucei brucei transitional bloodstream formsBIENEN, E. J; MUHAMED SARIC; POLLAKIS, G et al.Molecular and biochemical parasitology. 1991, Vol 45, Num 2, pp 185-192, issn 0166-6851Article

Deferixamine and eflornithine (DL-α-difluoromethylornithine) in a rat model of Pneumocystis carinii pneumoniaCLARKSON, A. B; SARIC, M; GRADY, R. W et al.Antimicrobial agents and chemotherapy. 1990, Vol 34, Num 9, pp 1833-1835, issn 0066-4804, 3 p.Article

Clinically achievable plasma deferoxamine concentrations are therapeutic in a rat model of Pneumocystis carinii pneumoniaMERALI, S; CHIN, K; DEL ANGEL, L et al.Antimicrobial agents and chemotherapy. 1995, Vol 39, Num 9, pp 2023-2026, issn 0066-4804Article

N-n-alkyl-3,4-dihydroxybenzamides as inhibitors of the trypanosome alternative oxidase : activity in vitro an in vivoGRADY, R. W; BIENEN, E. J; DIECK, H. A et al.Antimicrobial agents and chemotherapy. 1993, Vol 37, Num 5, pp 1082-1085, issn 0066-4804Article

Combination chemotherapy of drug-resistant Trypanosoma brucei rhodesiense infections in mice using DL-α-difluoromethylornithine and standard trypanocidesBACCHI, C. J; NATHAN, H. C; YARLETT, N et al.Antimicrobial agents and chemotherapy. 1994, Vol 38, Num 3, pp 563-569, issn 0066-4804Article

Characterization of a novel trans-sialidase of Trypanosoma brucei procyclic trypomastigotes and identification of procyclin as the main sialic acid acceptorPONTES DE CARVALHO, L. C; TOMLINSON, S; VANDEKERCKHOVE, F et al.The Journal of experimental medicine. 1993, Vol 177, Num 2, pp 465-474, issn 0022-1007Article

DNA probe for rRNA as a measurement of Pneumocystis carinii in rat lungsFAKIRI, E; POLLAKIS, G; SARIC, M et al.Methods in molecular and cellular biology. 1993, Vol 4, Num 4, pp 171-176, issn 0898-7750Article

Non-cytochrome mediated mitochondrial ATP production in bloodstream form Trypanosoma brucei bruceiBIENEN, E. J; MATURI, R. K; POLLAKIS, G et al.European journal of biochemistry (Print). 1993, Vol 216, Num 1, pp 75-80, issn 0014-2956Article

Efficacy of DL-α-difluoromethylornithine in a rat model of Pneumocystis carinii pneumoniaCLARKSON, A. B. JR; WILLIAMS, D. E; ROSENBERG, C et al.Antimicrobial agents and chemotherapy. 1988, Vol 32, Num 8, pp 1158-1163, issn 0066-4804Article

P-Alkyloxybenzhydroxamic acids, effective inhibitors of the trypanosome glycerol-3-phosphate oxidaseGRADY, R. W; BIENEN, E. J; CLARKSON, A. B. JR et al.Molecular and biochemical parasitology. 1986, Vol 19, Num 3, pp 231-240, issn 0166-6851Article

Efficacy of combinations of difluoromethylornithine and bleomycin in a mouse model of central nervous system African trypanosomiasisCLARKSON, A. B. JR; BACCHI, C. J; MELLOW, G. H et al.Proceedings of the National Academy of Sciences of the United States of America. Biological sciences. 1983, Vol 80, Num 18, pp 5729-5733, issn 0273-1134Article

Cure of Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense infectious in mice with an irreversible inhibitor of S-adenosylmethionine decarboxylaseBITONTI, A. J; BYERS, T. L; BUSH, T. L et al.Antimicrobial agents and chemotherapy. 1990, Vol 34, Num 8, pp 1485-1490, issn 0066-4804Article

Effects of the ornithine decarboxylase inhibitors DL-α-difluoromethylornithine and α-monofluoromethyldehydroornithine methyl ester alone and in combination with suramin against Trypanosoma brucei brucei central nervous system modelsBACCHI, C. J; NATHAN, H. C; CLARKSON, A. B. JR et al.The American journal of tropical medicine and hygiene. 1987, Vol 36, Num 1, pp 46-52, issn 0002-9637Article

New drug combination for experimental late-stage African trypanosomiasis: DL-α-difluoromethylornithine (DFMO) with suraminCLARKSON, A. B. JR; BIENEN, E. J; BACCHI, C. J et al.The American journal of tropical medicine and hygiene. 1984, Vol 33, Num 6, pp 1073-1077, issn 0002-9637Article

Inhibition of polyamine biosynthesis by α-difluoromethylornithine in African trypanosomes and Pneumocystis carinii as a basis chemotherapy: biochemical and clinical aspectsMCCANN, P. P; BACCHI, C. J; CLARKSON, A. B. JR et al.The American journal of tropical medicine and hygiene. 1986, Vol 35, Num 6, pp 1153-1156, issn 0002-9637Article